View of Prognostic value of early reduction of BCR/ABL1 gene expression in criteria of deep molecular response on imatynib therapy in patients with chronic myeloid leukemia

Return to Article Details Prognostic value of early reduction of BCR/ABL1 gene expression in criteria of deep molecular response on imatynib therapy in patients with chronic myeloid leukemia Download Download PDF